BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28902848)

  • 21. Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.
    Shah S; Ma Y; Scherzer R; Huhn G; French AL; Plankey M; Peters MG; Grunfeld C; Tien PC
    AIDS; 2015 Jul; 29(11):1325-33. PubMed ID: 25870985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage Activation and the Tumor Necrosis Factor Cascade in Hepatitis C Disease Progression Among HIV-Infected Women Participating in the Women's Interagency HIV Study.
    French AL; Martin JW; Evans CT; Peters M; Kessaye SG; Nowicki M; Kuniholm M; Golub E; Augenbraun M; Desai SN;
    J Acquir Immune Defic Syndr; 2017 Dec; 76(4):438-444. PubMed ID: 29077674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.
    Veenhuis RT; Astemborski J; Chattergoon MA; Greenwood P; Jarosinski M; Moore RD; Mehta SH; Cox AL
    Clin Infect Dis; 2017 Mar; 64(5):589-596. PubMed ID: 27927859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.
    Fuster D; Tsui JI; Cheng DM; Quinn EK; Armah KA; Nunes D; Freiberg MS; Samet JH
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1110-6. PubMed ID: 23601055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
    AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome.
    Aldámiz-Echevarría T; Berenguer J; Miralles P; Jiménez-Sousa MA; Carrero A; Pineda-Tenor D; Díez C; Tejerina F; Pérez-Latorre L; Bellón JM; Resino S
    PLoS One; 2016; 11(2):e0148537. PubMed ID: 26849641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virological Mechanisms in the Coinfection between HIV and HCV.
    Liberto MC; Zicca E; Pavia G; Quirino A; Marascio N; Torti C; Focà A
    Mediators Inflamm; 2015; 2015():320532. PubMed ID: 26494946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals.
    Rohrbach J; Stickel F; Schmid P; Thormann W; Kovari H; Scherrer A; Günthard HF; Vuichard D; Cavassini M; Ambrosioni J; Bernasconi E; Furrer H; Rauch A;
    Antivir Ther; 2014; 19(2):149-59. PubMed ID: 24036684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does HIV-1 co-receptor tropism correlate with fibrosis progression in HIV/HCV co-infected patients?
    Saracino A; Bruno G; Scudeller L; Punzi G; Lagioia A; Ladisa N; Monno L; Angarano G
    J Clin Virol; 2014 Mar; 59(3):167-71. PubMed ID: 24461764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.
    Bailony MR; Scherzer R; Huhn G; Plankey MW; Peters MG; Tien PC
    J Infect Dis; 2013 Dec; 208(11):1776-83. PubMed ID: 23901097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women.
    Strickler HD; Howard AA; Peters M; Fazzari M; Yu H; Augenbraun M; French AL; Young M; Gange S; Anastos K; Kovacs A
    AIDS; 2008 Feb; 22(4):527-31. PubMed ID: 18301066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.
    Gadalla SM; Preiss LR; Eyster ME; Goedert JJ
    J Viral Hepat; 2011 Mar; 18(3):161-9. PubMed ID: 20337924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.
    Shmagel KV; Saidakova EV; Shmagel NG; Korolevskaya LB; Chereshnev VA; Robinson J; Grivel JC; Douek DC; Margolis L; Anthony DD; Lederman MM
    HIV Med; 2016 Sep; 17(8):581-9. PubMed ID: 27187749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease.
    Berzsenyi MD; Woollard DJ; McLean CA; Preiss S; Perreau VM; Beard MR; Scott Bowden D; Cowie BC; Li S; Mijch AM; Roberts SK
    J Hepatol; 2011 Sep; 55(3):536-544. PubMed ID: 21266183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.
    Thong VD; Akkarathamrongsin S; Avihingsanon A; Theamboonlers A; Poovorawan Y; Tangkijvanich P
    Intervirology; 2015; 58(2):73-9. PubMed ID: 25677196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus replication in Caucasian HIV controllers.
    Ruiz-Mateos E; Machmach K; Romero-Sanchez MC; Ferrando-Martinez S; Viciana P; Del Val M; Muñoz-Fernandez MA; Genebat M; Leal M;
    J Viral Hepat; 2011 Jul; 18(7):e350-7. PubMed ID: 21692947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.